← THE EVIDENCE INDEXThe Study Library.
8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Showing studies that examined garlic. Clear
People assigned to a diet, food or program and measured.
3 studies
2020 / Randomized controlled trial (secondary analysis)
In a secondary analysis of a factorial randomized trial involving 3,365 adults followed for 22.3 years, smoking was associated with increased risk of gastric cancer incidence (OR, 1.72; 95% CI, 1.003-2.93) and mortality (HR, 2.01; 95% CI, 1.01-3.98). Garlic supplementation was associated with reduced gastric cancer mortality exclusively among individuals who never drank alcohol (HR, 0.33; 95% CI, 0.15-0.75; interaction P = .03). No significant interactions occurred between vitamin supplementation and lifestyle behaviors.
Guo Y, Li ZX, Zhang JY, et al. JAMA Netw Open, 2020. PMID 32589229
2019 / Randomized controlled trial
During 22 years of follow-up in 3,365 residents, garlic supplementation for 7.3 years significantly reduced gastric cancer mortality (hazard ratio 0.66, 95% CI 0.43 to 1.00), though it did not significantly reduce incidence (odds ratio 0.81, 95% CI 0.57 to 1.13). Vitamin supplementation significantly lowered both gastric cancer mortality (hazard ratio 0.48, 95% CI 0.31 to 0.75) and incidence (odds ratio 0.64, 95% CI 0.46 to 0.91).
Li WQ, Zhang JY, Ma JL, et al. BMJ, 2019. PMID 31511230
2012 / Masked factorial randomized placebo-controlled trial
Participants were tracked for 14.7 years following interventions in the Shandong Intervention Trial. Long-term supplementation with garlic or vitamins (C, E, and selenium) was linked to non-statistically significant decreases in gastric cancer incidence and mortality. However, vitamin supplementation significantly lowered combined deaths from gastric or esophageal cancer (hazard ratio = 0.51, 95% CI = 0.30 to 0.87; P = .014).
Ma JL, Zhang L, Brown LM, et al. J Natl Cancer Inst, 2012. PMID 22271764